Tag: Reputation
News alerts
Latest content
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea

- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment

- Ipsen announces new data on Dysport in neurological disease

- PMGroup Worldwide Ltd welcomes MAD World Summit

- Argenx receives review from FDA for VYVGART in seronegative gMG

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
